73 related articles for article (PubMed ID: 8598310)
1. Human papillomavirus--the most significant risk determinant of cervical intraepithelial neoplasia.
Kjaer SK; van den Brule AJ; Bock JE; Poll PA; Engholm G; Sherman ME; Walboomers JM; Meijer CJ
Int J Cancer; 1996 Mar; 65(5):601-6. PubMed ID: 8598310
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study on cervical intraepithelial lesions of low-grade and undetermined significance: evolution, associated factors and cytohistological correlation.
Silva C; Almeida EC; Côbo Ede C; Zeferino VF; Murta EF; Etchebehere RM
Sao Paulo Med J; 2014; 132(2):92-6. PubMed ID: 24714989
[TBL] [Abstract][Full Text] [Related]
3. Multifactorial etiology of cervical cancer: a hypothesis.
Haverkos HW
MedGenMed; 2005 Nov; 7(4):57. PubMed ID: 16614679
[TBL] [Abstract][Full Text] [Related]
4. Assessing the potential association between Epstein-Barr virus and oral squamous cell carcinoma: a systematic review and meta-analysis.
Sivakumar S; Gupta AA; Nik Mohd Rosdy NMM; Venkiteswaran A; Raj AT; Awan KH
Transl Cancer Res; 2020 Apr; 9(4):3092-3100. PubMed ID: 35117672
[TBL] [Abstract][Full Text] [Related]
5. Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the "HPVinHIV" Trial.
Cavallari EN; Ceccarelli G; Santinelli L; Innocenti GP; De Girolamo G; Borrazzo C; Spagnolello O; Scagnolari C; Arcieri S; Ciardi A; Pierangeli A; Mastroianni CM; d'Ettorre G
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829967
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.
Angelopoulou A; Alexandris N; Konstantinou E; Mesiakaris K; Zanidis C; Farsalinos K; Poulas K
Environ Res; 2020 Sep; 188():109858. PubMed ID: 32846644
[TBL] [Abstract][Full Text] [Related]
7. Role of polycyclic aromatic hydrocarbons as a co-factor in human papillomavirus-mediated carcinogenesis.
Zhang C; Luo Y; Zhong R; Law PTY; Boon SS; Chen Z; Wong CH; Chan PKS
BMC Cancer; 2019 Feb; 19(1):138. PubMed ID: 30744599
[TBL] [Abstract][Full Text] [Related]
8. Changes in human papillomavirus genotypes associated with cervical intraepithelial neoplasia grade 2 lesions in a cohort of young women (2013-2016).
Innes CR; Sykes PH; Harker D; Williman JA; Van der Griend RA; Whitehead M; Hibma M; Lawton BA; Fitzgerald P; Dudley NM; Petrich S; Faherty J; Bergzoll C; Eva L; Sadler L; Simcock BJ
Papillomavirus Res; 2018 Dec; 6():77-82. PubMed ID: 30391363
[TBL] [Abstract][Full Text] [Related]
9. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
[TBL] [Abstract][Full Text] [Related]
10. Impact of model calibration on cost-effectiveness analysis of cervical cancer prevention.
Moriña D; de Sanjosé S; Diaz M
Sci Rep; 2017 Dec; 7(1):17208. PubMed ID: 29222509
[TBL] [Abstract][Full Text] [Related]
11. Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination.
Fischer S; Bettstetter M; Becher A; Lessel M; Bank C; Krams M; Becker I; Hartmann A; Jagla W; Gaumann A
Oncol Lett; 2016 Jul; 12(1):601-610. PubMed ID: 27347187
[TBL] [Abstract][Full Text] [Related]
12. Detection of Human Papillomavirus Infections at the Single-Cell Level.
Shen Z; Liu X; Morihara J; Hulbert A; Koutsky LA; Kiviat NB; Xi LF
Intervirology; 2015; 58(5):324-331. PubMed ID: 26820741
[TBL] [Abstract][Full Text] [Related]
13. High-risk human papillomavirus and cervical lesions among women living with HIV/AIDS in Brazilian Amazon, Brazil.
Silva Ld; Miranda A; Batalha R; Ferreira L; Santos M; Talhari S
Braz J Infect Dis; 2015; 19(6):557-62. PubMed ID: 26260194
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease.
Thomas A; Mahantshetty U; Kannan S; Deodhar K; Shrivastava SK; Kumar-Sinha C; Mulherkar R
Cancer Med; 2013 Dec; 2(6):836-48. PubMed ID: 24403257
[TBL] [Abstract][Full Text] [Related]
15. HPV genotyping 9G membrane test.
Sayyed DR; Song KS; Nimse SB; An H; Kim J; Kim T
Viruses; 2013 Nov; 5(11):2840-55. PubMed ID: 24284877
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study.
Haghshenas M; Golini-Moghaddam T; Rafiei A; Emadeian O; Shykhpour A; Ashrafi GH
Infect Agent Cancer; 2013 Jun; 8(1):20. PubMed ID: 23738651
[TBL] [Abstract][Full Text] [Related]
17. HPV 9G DNA chip: 100% clinical sensitivity and specificity.
An H; Song KS; Nimse SB; Kim J; Nguyen VT; Ta VT; Sayyed DR; Kim T
J Clin Microbiol; 2012 Mar; 50(3):562-8. PubMed ID: 22170909
[TBL] [Abstract][Full Text] [Related]
18. Methods of model calibration: observations from a mathematical model of cervical cancer.
Taylor DC; Pawar V; Kruzikas D; Gilmore KE; Pandya A; Iskandar R; Weinstein MC
Pharmacoeconomics; 2010; 28(11):995-1000. PubMed ID: 20936883
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women.
Nielsen A; Iftner T; Munk C; Kjaer SK
Sex Transm Dis; 2009 Oct; 36(10):609-15. PubMed ID: 19955872
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immune responses to human papillomavirus 16 E6 and E7 antigens as measured by interferon gamma enzyme-linked immunospot in women with cleared or persistent human papillomavirus infection.
Farhat S; Nakagawa M; Moscicki AB
Int J Gynecol Cancer; 2009 May; 19(4):508-12. PubMed ID: 19509544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
